Материал: MasterPass _ Pharmacology in 7 Days for Medical Students

Внимание! Если размещение файла нарушает Ваши авторские права, то обязательно сообщите нам

PHARMACOLOGY IN 7 DAYS FOR MEDICAL STUDENTS

For supraventricular tachycardia (SVT): Verapamil.

For ventricular tachycardia (VT): Lignocaine; phenytoin.

Digoxin toxicity: indications of digoxin-binding antibody fragment9

1Reserved for very severe cases:

Patients who have taken a large overdose (≥10 mg in adults and ≥4 mg in children).

Serum digoxin level >13nmol/L.

Serum K+ level >5mmol/L.

Presence of life-threatening arrhythmias (2nd or 3rd degree AV block; VT; VF).

Aspirin/salicylate toxicity

It could be mild (called salicylism) or severe.

Mild toxicity: features

GI: N, V.

Respiratory: Hyperventilation (salicylate toxicity → metabolic acidosis → hyperventilation).

CNS: Headache; dizziness; tinnitus (ringing of ears).

Severe toxicity: features

Symptoms of mild toxicity are followed by restlessness, delirium, hallucinations, convulsions and coma. The usual cause of death is respiratory failure.

Lethal dose

In children: ≥10 gm

In adults: 300 mg/kg

Investigations

1Serum salicylate levels (levels of >70 mg/dl indicate severe intoxication).

2Arterial blood gases (to determine pH): It will initially show respiratory alkalosis (d/t hyperventilation) followed by metabolic acidosis (d/t drug itself).

Treatment

Mild cases:

1Symptomatic.

2Alkaline diuresis (NaHCO3 added in dextrose water → alkalisation of urine → increasing the urinary pH enhances the elimination of salicylate).

Severe cases:

1Haemodialysis.

2Mechanical ventilation (if pulmonary oedema develops).

3Intravenous mannitol (if cerebral oedema develops).

Acetaminophen (paracetamol) toxicity

Acetaminophen is acted upon by cytochrome P450 mixed-function oxidase to form a toxic intermediate (called N-acetyl-p-benzoquinoneimine). In therapeutic doses, this

9Normally given as I/V infusion over 30 minutes. In cases of cardiac arrest, it can be given as I/V bolus. It freely filters through the kidneys and thus can be given even in CRF patients.

144

MISCELLANEOUS

toxic intermediate conjugates with hepatic glutathione to form non-toxic mercapturic acid. In lethal doses, all available glutathione reserves of the liver are depleted and the toxic intermediate combines with the essential hepatic cell proteins, resulting in cell death/hepatic necrosis – a potentially life-threatening condition (renal tubular necrosis can also occur → acute renal failure).

In patients who are already suffering from some chronic liver disease, the glutathione reserves may be subnormal so that even near-normal doses of paracetamol may cause hepatic necrosis.

Treatment

If given within 10 hours of paracetamol toxicity, N-acetylcysteine, which contains sulfhydryl groups to which the toxic intermediate can bind, is life-saving.

145

7

Important tables

Table 7.1 Important receptors and their agonists and antagonists

Receptor

Agonist/s

Antagonist/s

5-HT2-receptor

5-Hydroxytryptamine

Ketanserine

D2-receptor

Dopamine

Chlorpromazine

 

Bromocriptine

 

Mu (µ) receptor

Morphine

Naloxone

β-adrenoceptor

Noradrenaline

Propranolol

 

Isoprenaline

 

Nicotinic ACh receptor

Acetylcholine

Tubocurarine

 

Nicotine

 

H1-receptor

Histamine

Mepyramine

H2-receptor

Impromidine

Cimetidine

 

 

Ranitidine

Insulin receptor

Insulin

Not known

Oestrogen receptor

Ethinylestradiol

Tamoxifen

Progesterone receptor

Norethisterone

Danazol

 

 

 

146

Table 7.2 Main effects of autonomic nervous system

Structure

Parasympathetic effect

Receptor involved

Sympathetic effect

Receptor

 

 

 

 

involved

 

 

 

 

 

Eye: pupils

Constriction

M3

Dilatation

α

Eye: ciliary muscle

Contraction

M3

Relaxation

β

Lacrimal gland

Secretion

M3

No effect

Ð

Salivary glands

Secretion (we salivate when we

M3

No effect

α, β

 

are about to eat)

 

 

 

Skin: sweat glands

No effect

Ð

Secretion (when we Þght, we

α

 

 

 

sweat)

 

Skin: pilomotor

No effect

Ð

Piloerection

α

Airways

Constriction

M3

Dilatation

β2

Mast cells

 

 

Inhibition of histamine release

β2

SA node

↓ Heart rate

M2

↑ Heart rate

β1

AV node

Speed of conduction slowed

M2

Speed of conduction made fast

β1

Myocardium

↓ Force of contraction (only atria

M2

↑ Force of contraction (both

β1

 

affected; ventricles spared)

 

atria and ventricles affected)

 

 

 

 

 

 

(continued)

TABLES IMPORTANT

147

148

Table 7.2 Main effects of autonomic nervous system (continued)

Structure

Parasympathetic effect

Receptor involved

Sympathetic effect

Receptor

 

 

 

 

involved

Arterioles:

Except arterioles of erectile

M3

¥

Brain

tissue and salivary glands, which

 

¥

Coronary

are dilated, parasympathetic

 

¥

Cutaneous

system does not affect arterioles

 

¥

Erectile tissue

elsewhere

 

¥Salivary glands

¥Skeletal muscles

¥Visceras

Sympathetic system affects all

It is α-receptor

arteriolar beds mentioned on

everywhere,

the left. It causes dilatation of

except skeletal

the skeletal muscle arterioles.

muscles where

At rest of the places it causes

β2 receptors are

constriction

stimulated

Veins

No effect

Ð

Constriction

α

 

 

 

Dilatation

β2

Platelets

 

 

Aggregation

α2

GI smooth muscles

↑ Motility

M3

↓ Motility

α1, α2, β2

GI sphincters

Dilatation

M3

Constriction

α2, β2

GI glands

Secretion

M3

No effect

Ð

Gastric acid secretion

M1

No effect

 

Pancreatic islets secretion

↑ Insulin secretion

 

↓ Insulin secretion

α2

Liver

No effect

Ð

↑ Glucose output (by

α1, β2

 

 

 

↑ glycogenolysis and

 

 

 

 

gluconeogenesis)

 

Kidney

No effect

Ð

Renin secretion (when we

β2

Þght, body tries to conserve the water)

(continued)

STUDENTS MEDICAL FOR DAYS 7 IN PHARMACOLOGY